Clinical Care Considerations for COVID-19 Vaccination
National Center for Immunization and Respiratory Diseases. (2021). Clinical Care Considerations for COVID-19 Vaccination. Centers for Disease Control and Prevention.
This page provides updates on Advisory Committee on Immunization Practices recommendations and clinical considerations for managing adverse events for the use of Pfizer-BioNTech, Moderna, and Janssen/Johnson & Johnson COVID-19 vaccines for the prevention of COVID-19 in the U.S..